Decheng Capital LLC
CIK: 0002010850SEC EDGAR →
Portfolio Value
$743.4M
Holdings
19
As of
Q4 2025
New Positions
23
Closed Positions
0
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | 6,371,669 | $264.6M | 35.59% |
| 2 | Nuvation Bio Inc. | 25,954,439 | $232.6M | 31.28% |
| 3 | Nuvation Bio Inc. | 646,057 | $213.0M | 28.65% |
| 4 | Upstream Bio Inc. | 3,143,078 | $85.3M | 11.48% |
| 5 | AARDVARK THERAPEUTICS INC | 3,917,299 | $51.4M | 6.92% |
| 6 | Lyell Immunopharma, Inc. | 692,050 | $21.3M | 2.87% |
| 7 | NEWAMSTERDAM PHARMA CO NV | 592,057 | $20.8M | 2.79% |
| 8 | REVOLUTION MEDICINES INC(NSM) | 200,000 | $15.9M | 2.14% |
| 9 | Arcus Biosciences, Inc | 541,559 | $12.9M | 1.74% |
| 10 | Aclaris Therapeutics, Inc. | 4,041,736 | $12.2M | 1.64% |
Quarterly Changes
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 18 | $743.2M | 77.7% |
| Unknown | 1 | $213.0M | 22.3% |